腹膜透析
医学
透析
尿毒症毒素
重症监护医学
药方
泌尿科
肌酐
尿素
尿毒症
内科学
血液透析
化学
药理学
生物化学
作者
Timothy W. Meyer,Joanne M. Bargman
出处
期刊:Journal of The American Society of Nephrology
日期:2023-08-09
卷期号:34 (12): 1919-1927
被引量:2
标识
DOI:10.1681/asn.0000000000000211
摘要
ABSTRACT Peritoneal dialysis (PD) is now commonly prescribed to achieve target clearances for urea or creatinine. The International Society for Peritoneal Dialysis has proposed however that such targets should no longer be imposed. The Society's new guidelines suggest rather that the PD prescription should be adjusted to achieve well-being in individual patients. The relaxation of treatment targets could allow increased use of PD. Measurement of solute levels in patients receiving dialysis individualized to relieve uremic symptoms could also help us identify the solutes responsible for those symptoms and then devise new means to limit their accumulation. This possibility has prompted us to review the extent to which different uremic solutes are removed by PD.
科研通智能强力驱动
Strongly Powered by AbleSci AI